INDSWFTLAB

Ind-Swift Laboratories Share Price

₹115.20 -4.71 (-3.93%)

05 Nov, 2024 17:29

SIP TrendupStart SIP in INDSWFTLAB

Start SIP

Performance

  • Low
  • ₹115
  • High
  • ₹115
  • 52 Week Low
  • ₹89
  • 52 Week High
  • ₹186
  • Open Price₹0
  • Previous Close₹118
  • Volume11,128

Investment Returns

  • Over 1 Month -9.28%
  • Over 3 Month -34.77%
  • Over 6 Month -0.69%
  • Over 1 Year + 30.17%
SIP Lightning

Smart Investing Starts Here Start SIP with Ind-Swift Laboratories for Steady Growth!

Ind-Swift Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 2.3
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 681
  • P/B Ratio
  • 0.7
  • Average True Range
  • 4.13
  • EPS
  • 23.3
  • Dividend Yield
  • 0
  • MACD Signal
  • -4.28
  • RSI
  • 43.27
  • MFI
  • 63.54

Ind-Swift Laboratories Financial

IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations30.46381.73276.28270.30299.01
Total Income From Operations30.46381.73276.28270.30299.01
P/L Before Interest, Excpt. Items & Tax6.3685.0847.3857.6151.48
P/L Before Exceptional Items & Tax6.1996.5626.3336.4731.10
P/L After Tax from Ordinary Activities6.19349.5921.6530.1017.05
Net Profit/Loss For the Period6.19349.5921.6530.1017.05
IndicatorMar 24Mar 23
Revenue From Operations [Gross]1,227.321,151.96
Revenue From Operations [Net]1,227.321,151.96
Total Operating Revenues1,227.321,151.96
Total Revenue1,272.631,185.24
Total Expenses1,081.751,079.39
Profit/Loss Before Tax577.4779.20
Profit/Loss For The Period418.3942.47
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity-179.77182.67
Net Cash Used In Investing Activity-104.32-13.69
Net Cash Used in Finance Activity699.86-168.41
Net Inc/Dec In Cash And Equivalent415.770.58
Cash And Equivalent End Of Year425.739.96
IndicatorMar 24Mar 23
Total Share Capital59.0959.81
Total Non-Current Liabilities4.22762.88
Total Current Liabilities178.32350.05
Total Capital And Liabilities1,104.791,788.27
Total Non-Current Assets559.25714.20
Total Current Assets545.541,074.07
Total Assets1,104.791,788.27
Indicator20242023
EBIT Margin (%)19.7117.18
Return On Capital Employed (%)26.1113.76
Return On Equity (%)45.368.63
Long Term Debt To Equity (%)0.32151.32
Book Value/Share (INR)156.0882.26
IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations33.17393.33287.51289.71310.34
Total Income From Operations33.17393.33287.51289.71310.34
P/L Before Interest, Excpt. Items & Tax1.15-24.7244.8359.9052.02
P/L Before Exceptional Items & Tax0.98-13.2523.7838.7731.64
P/L After Tax from Ordinary Activities1.01238.8719.5331.8317.40
Net Profit/Loss For the Period1.01238.8719.5331.8317.40
IndicatorMar 24Mar 23
Revenue From Operations [Gross]1,280.901,207.31
Revenue From Operations [Net]1,280.901,207.31
Total Operating Revenues1,280.901,207.31
Total Revenue1,326.271,240.81
Total Expenses1,131.101,127.64
Profit/Loss Before Tax581.7686.52
Profit/Loss For The Period421.4547.83
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity-180.87194.62
Net Cash Used In Investing Activity-104.32-13.37
Net Cash Used in Finance Activity698.91-185.66
Net Inc/Dec In Cash And Equivalent413.28-3.28
Cash And Equivalent End Of Year431.9318.20
IndicatorMar 24Mar 23
Total Share Capital59.0959.81
Total Non-Current Liabilities12.39771.04
Total Current Liabilities221.28371.09
Total Capital And Liabilities1,165.111,824.06
Total Non-Current Assets503.98659.55
Total Current Assets661.131,164.52
Total Assets1,165.111,824.06
Indicator20242023
EBIT Margin (%)19.2217.00
Return On Capital Employed (%)26.0914.13
Return On Equity (%)45.199.54
Long Term Debt To Equity (%)1.19150.96
Book Value/Share (INR)157.6483.36

Ind-Swift Laboratories Technicals

EMA & SMA

Current Price
₹115.20
-4.71 (-3.93%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹120.17
  • 50 Day
  • ₹126.98
  • 100 Day
  • ₹128.43
  • 200 Day
  • ₹121.89

Resistance and Support

118.31 Pivot Speed
  • R3 121.49
  • R2 120.70
  • R1 119.10
  • S1 116.71
  • S2 115.92
  • S3 114.32

Is Ind-Swift Laboratories Worth Buying?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ind-Swift Labs. (Nse) has an operating revenue of Rs. 1,003.73 Cr. on a trailing 12-month basis. An annual revenue growth of 7% is good, Pre-tax margin of 45% is great, ROE of 45% is exceptional. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 22 which is a POOR score indicating inconsistency in earnings, a RS Rating of 27 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 32 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Ind-Swift Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-08-12 Quarterly Results
2024-06-27 Preferential issue of shares
2024-05-13 Audited Results
2024-02-12 Quarterly Results
2023-11-07 Quarterly Results

Ind-Swift Laboratories F&O

Ind-Swift Laboratories Shareholding Pattern

42%
0.65%
36.63%
20.72%
  • NSE Symbol
  • INDSWFTLAB
  • BSE Symbol
  • 532305
  • Chairman & Managing Director
  • Mr. Navrattan Munjal
  • ISIN
  • INE915B01019

Ind-Swift Laboratories FAQs

Ind-Swift Laboratories share price is ₹115 As on 05 November, 2024 | 17:15

The Market Cap of Ind-Swift Laboratories is ₹680.7 Cr As on 05 November, 2024 | 17:15

The P/E ratio of Ind-Swift Laboratories is 2.3 As on 05 November, 2024 | 17:15

The PB ratio of Ind-Swift Laboratories is 0.7 As on 05 November, 2024 | 17:15

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form